%PDF-1.3
%
1 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
xK =.Rխ.\
^I&|WD+@NT( 5͝r;,xN}
g҂>Ҁ38.N.yh)b,
c,(c>lUW~b>1q,y
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
xK =.Rխ.\
^I&|WD+@NT( 5͝r;,xN}
g҂>Ҁ38.N.yh)b,
c,(c>lUW~b>1q,y
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 140>>stream
xK =.Rխ.\
^I&|WD+@NT( 5͝r;,xN}
g҂>Ҁ38.N.yh)b,
c,(c>lUW~b>1q,y
endstream
endobj
6 0 obj
<>stream
2018-09-19T10:56:57+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2018-09-23T14:54:48-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
PHO-2018-4527-ver9-Liebert_2P 1..3
uuid:0e0ecffa-8f48-43c3-b690-625ad3463519
uuid:e45cab7c-f118-4d2a-98fa-d17066272079
endstream
endobj
7 0 obj
<>stream
x+ |
endstream
endobj
8 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
14 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(the)-361.7(body.)-353.4(The)-357(microbiome)-361.6(is)-359.2(the)-361.7(sum)-355.7(of)-359.3(the)-355.9(collective)-361.8(ge-)]TJ
0 -1.1174 TD
[(nomes)-359(of)-353.5(the)-361.7(commensal)-361.4(microbiota)-360.5(that)-357.2(live)-357.2(within)-359.2(us)-353.3(all)]TJ
0 -1.1116 TD
[(\(gut,)-342(oral,)-343.2(urogenital,)-345.4(etc.\).)-342(T)-13.8(h)-12.6(e)-359.4(s)-12.4(u)-12.6(m)-353.7(o)-18.4(f)-352.4(t)-12.7(h)-18.4(e)-353.6(i)-12.7(n)-18.4(t)-12.7(e)-13.8(r)-12.6(a)-19.5(c)-13.8(t)-12.7(i)-18.5(o)-12.6(n)-352.4(b)-12.6(e)-19.5(-)]TJ
T*
.0128 Tc
[(tw)-6.4(een)-282(th)-5.6(e)-283.2(g).2(eno)-5.6(m)-1(ic)-283.2(re)-6.7(spon)-5.6(ses)-281.8(o)-5.6(f)-282(our)-282(c)-6.7(e)-1(lls)-281.8(a)-6.7(n).2(d)-282(t).1(he)-283.2(g)-5.6(e)-1(nom)-6.8(ic)]TJ
T*
.013 Tc
[(ac)-6.5(tion)-5.4(s)-431.4(o)-5.4(f)-431.6(t)-5.5(h).4(e)-432.8(m)-6.6(icro)-5.4(bio)-5.4(t).3(a)-432.8(i)-5.5(s)-431.4(l)-5.5(abe)-6.5(l).3(ed)-437.3(the)-438.5(hol)-5.5(obi)-5.5(ome.)-433.9(T)-6.6(h).4(e)]TJ
0 -1.1174 TD
[(in)-5.4(ter)-5.3(acti)-5.5(ons)-414.1(bet)-5.5(w)-.5(een)-414.3(th)-5.4(e)-409.7(m)-.8(ic)-6.5(rob)-5.4(ial)-414.4(a)-.8(nd)-414.3(the)-415.5(hos)-5.2(t)-408.7(m)-.8(e)-6.5(t).3(abo)-5.4(-)]TJ
0 -1.1116 TD
[(li)-5.6(tes)-281.7(a)-.9(re)-283.1(cal)-5.6(led)-281.9(t).2(he)-283.1(hol)-5.6(obio)-5.5(n).3(t.)-278.5(T)-6.7(h).3(ere)-283.1(i).2(s)-281.7(i).2(nc)-6.6(rea)-6.6(s).5(ing)-281.9(e)-.9(v)-5.5(i).2(den)-5.5(c)-.9(e)]TJ
T*
[(fo)-5.5(r)-454.7(t)-5.6(he)-461.7(in)-5.3(u).3(enc)-6.6(e)-455.9(o)-5.5(f)-454.7(t)-5.6(h).3(e)-461.7(m)-.9(icr)-5.4(obio)-5.5(m)-.9(e)-461.7(o).3(n)-460.5(a)-455.9(di)-5.6(ver)-5.4(s).5(e)-461.7(r).3(an)-5.5(ge)]TJ
0 -1.1174 TD
.0143 Tc
[(of)-361.1(diseases.)-363.5(T).5(here)-356.6(is)-361(ample)-356.6(e)-5.2(v)]TJ
12.9305 0 TD
.013 Tc
[(id)-5.4(ence)-363.6(of)-362.4(a)-357.9(g).4(u)-5.4(t).3(b)-5.4(rain)-362.5(axi)-5.5(s).6(,)]TJ
-12.9305 -1.1116 TD
[(wh)-5.4(ere)-369.4(c)-.8(han)-5.4(g).4(es)-368(in)-362.5(t)-5.5(h).4(e)-363.6(g).4(u)-5.4(t)-362.6(mi)-5.5(crob)-5.4(iome)-369.4(are)-369.4(s).6(tr)-5.3(ong)-5.4(ly)-362.5(c)-6.5(orre)-6.5(-)]TJ
T*
[(la)-6.5(ted)-425.8(w)-6.2(ith)-425.8(a)-432.8(numb)-5.4(e)-.8(r)-425.8(o).4(f)-431.6(n).4(eu)-5.4(rolo)-5.4(g).4(ic)-6.5(al)-426(co)-5.4(ndit)-5.5(i).3(on)-5.4(s)-425.6(a)-.8(n)-5.4(d)-425.8(dis)-5.2(-)]TJ
0 -1.1174 TD
[(ea)-6.5(ses)-5.2(,)-428.2(s)-5.2(u).4(ch)-437.4(as)-431.4(fe)-6.5(ar)-431.6(an)-5.4(d)-431.6(r).4(i)-5.5(s).6(k-)-5.3(taki)-5.5(ng)-431.6(be)-6.5(hav)-5.4(i).3(ors)-5.2(,)-433.9(c)-.8(ogn)-5.4(iti)-5.5(on,)]TJ
0 -1.1116 TD
[(sc)-6.5(hiz)-6.5(ophr)-5.3(eni)-5.5(a)-.8(,)-324.5(d).4(e)-6.5(pre)-6.5(ssi)-5.5(on,)-330.2(and)-327.9(n).4(eu)-5.4(rol)-5.5(ogi)-5.5(cal)-328(dis)-5.2(eas)-5.2(es)-327.7(su)-5.4(ch)]TJ
T*
.0133 Tc
[(as)-338.9(PD)-334.2(and)-339.1(AD.)]TJ
1.0137 -1.1116 TD
0 Tc
[(The)-316.7(microbiome)-321.3(also)-316.5(has)-315.3(a)-319(direct)-320.2(inuence)-317.5(on)-313.2(metabolic)]TJ
-1.0137 -1.1174 TD
[(diseases)-397.7(and)-390.4(cardiovascular)-395.6(disease)-396.8(\(summarized)-392.3(by)-388.1(Bick-)]TJ
0 -1.1116 TD
[(nell)-391.7(et)-395.1(al.)]TJ
7.3823 0 0 6.5614 101.4236 554.1731 Tm
(11)Tj
9.843 0 0 9.843 108.7937 549.8077 Tm
[(\).)-396.2(Although)-390.1(the)-396.3(denition)-391.4(of)-393.8(metabolomics)-393.7(ex-)]TJ
-4.7518 -1.1116 TD
[(pressly)-273.5(exclu)-8(des)-269.2(the)-275.3(microbiome)-281(as)-273.9(a)-273(factor,)-277.4(the)-275.3(mechanism)]TJ
0 -1.1174 TD
[(of)-267.1(PBMt)-265.5(action)-268.4(should)-271.5(take)-266(this)-269.4(important)-266.1(component)-267(of)-267.1(the)]TJ
0 -1.1116 TD
[(body)-344.2(into)-344.5(account,)-348.8(given)-340.9(the)-344.4(demonstrated)-352(inuence)-346.3(of)-342(the)]TJ
T*
[(microbiome)-355.9(on)-353.5(an)-354.7(individuals)-360.3(health)-354.8(and)-355.8(diseases)-357.4(and)-355.8(the)]TJ
0 -1.1174 TD
[(two-way)-408.1(communication)-412.3(between)-409.6(the)-407.8(microbiome)-407.7(and)-407.6(the)]TJ
0 -1.1116 TD
[(body.)-411(Many)-409.7(of)-411.1(the)-413.5(diseases)-415(that)-409(are)-414.5(known)-409.6(to)-411.3(be)-412.3(directly)]TJ
T*
[(inuenced)-295.6(by)-284.4(the)-292.6(microbiome)-292.5(are)-287.8(also)-293.5(modulated)-290.2(by)-290.2(PBMt.)]TJ
1.0137 -1.1174 TD
[(In)-318.9(our)-325.8(laboratories,)-325.5(we)-321(have)-323.5(shown)-323(that)-322.6(PBMt,)-320.8(delivered)]TJ
-1.0137 -1.1116 TD
[(as)-394.8(laser)-393.6(light)-391.8(\(660)-396(and)-390.4(808)-164.6(nm\),)-393.8(is)-393.8(able)-392.8(to)-394(change)-396(the)-390.5(mi-)]TJ
T*
[(crobiome)-421.4(in)-422.8(a)-422.7(mouse)-416.6(model.)-426.2(In)-416.9(particular,)-427.2(one)-419.2(species)-425.6(of)]TJ
T*
[(bacterium)-418(\()]TJ
/F7 1 Tf
4.769 0 TD
(Allobaculum)Tj
/F6 1 Tf
5.1261 0 TD
[(\))-410(was)-414.1(shown)-415.1(to)-411.3(increase)-422.3(as)-412.1(a)-411.2(pro-)]TJ
-9.8952 -1.1174 TD
[(portion)-336.2(of)-336.2(the)-332.9(microbiota)-337.5(when)-340.5(infrared)-333.7(laser)-336(was)-339.2(adminis-)]TJ
0 -1.1116 TD
[(tered)-745.2(regularly)-743.9(over)-748.5(a)-739.5(14-day)-745(period.)-742.8(This)-742.8(particular)]TJ
T*
[(bacterium)-314.4(is)-307.4(strongly)-308.3(associated)-315(with)-305(a)-313.3(healthy)-309.8(microbiome)]TJ
0 -1.1174 TD
[(in)-255.8(the)-252.3(mouse)-255.4(and)-257.9(can)-253.3(be)-256.8(increased)-262.1(with)-253.2(other)-254.4(treatments)-257.8(that)]TJ
0 -1.1116 TD
[(target)-285.6(the)-281.1(microbiome,)-290.2(such)-281.8(as)-285.4(the)-281.1(diabetic)-289.2(drug,)-278.5(metformin)]TJ
T*
[(\(reviewed)-336.9(b)-12.6(y)-346.7(B)-7.9(i)-12.7(c)-13.8(k)-6.9(n)-12.6(e)-13.8(l)-12.7(l)-341(e)-13.8(t)-341(a)-13.8(l)-12.7(.)]TJ
7.3823 0 0 6.5614 176.4283 367.8802 Tm
.0145 Tc
(11)Tj
9.843 0 0 9.843 184.0251 363.5149 Tm
.0126 Tc
(\).)Tj
-11.3812 -1.1174 TD
0 Tc
[(In)20.9(te)19.6(re)19.7(st)15.1(in)20.7(gl)20.7(y,)-373.2(Bl)13.9(iv)20.7(et)-372.1(et)-377.9(al)19.5(.)]TJ
7.3823 0 0 6.5614 174.6141 356.9385 Tm
(12)Tj
9.843 0 0 9.843 185.7259 352.5164 Tm
[(ha)19.7(ve)-372(de)13.9(mo)19.6(ns)21(tr)20.7(at)19.5(ed)-377.7(th)20.7(at)-377.9(a)-388.2(r)0(e)19.7(-)]TJ
-12.5677 -1.1116 TD
[(du)20.8(ct)19.5(io)15(n)-317.9(o)0(f)-307.4(A)0(l)19.8(z)0(h)19.7(e)0(i)19.5(m)0(e)18.4(r)0()20.9(s)-323.4(sy)21(mp)19.6(to)20.7(ms)-308.5(oc)19.7(cu)19.7(rs)-313(in)-307.6(a)-319(m)0(o)19.6(u)0(s)21(e)-319(mo)19.6(de)19.7(l,)]TJ
T*
[(us)21(in)15(g)-438.8(a)-440(co)13.9(m)15(b)0(i)15(n)0(a)19.7(t)0(i)20.6(o)0(n)-434.2(o)0(f)-428.4(l)0(a)19.6(s)0(e)19.9(r)-444.6(an)19.7(d)-444.6(L)0(E)18.4(D)-439.7(wa)18.8(ve)19.7(le)19.5(ng)15.1(th)20.7(s)-438.6(a)0(n)19.7(d)-444.6(a)]TJ
T*
[(st)20.9(at)13.8(ic)-366.4(ma)18.4(gn)20.8(et)19.5(ic)-366.3(e)19.8(ld)15(,)-372(w)0(h)14.2(e)0(n)-366.2(b)0(o)20.8(t)0(h)-365.2(t)0(h)20.7(e)-382.4(he)19.7(ad)-366.2(an)19.7(d)-375.5(a)0(b)19.7(d)0(o)15.1(m)15(en)-372(ar)19.7(e)]TJ
0 -1.1174 TD
[(tr)20.7(ea)18.5(te)13.8(d,)-465.3(bu)15.1(t)-479.3(n)0(o)20.8(t)-479.3(wh)14.2(en)-469.9(ei)19.5(th)20.7(er)-469.9(is)-474.4(tr)20.7(ea)18.5(te)19.6(d)-484.9(a)0(l)19.5(o)0(n)20.8(e)0(.)-472.2(T)0(h)19.6(e)-480.3(au)19.7(th)20.7(or)15.1(s)]TJ
0 -1.1116 TD
[(su)21(gg)15.1(es)19.9(t)-231.6(t)0(h)15(a)0(t)-222.4(t)0(h)15(e)-232.6(mi)19.5(cr)13.9(ob)20.8(io)20.7(me)-223.5(ma)18.4(y)-237.2(p)0(l)20.7(a)0(y)-228(a)-238.4(ro)20.9(le)-228.1(in)-227(th)20.7(is)-226.8(tr)20.7(ea)18.5(tm)19.5(en)19.7(t.)]TJ
1.0137 -1.1116 TD
[(The)-437.6(delay)-439.9(in)-440.1(the)-442.3(response)-436.9(of)-439.9(the)-442.3(microbiome)-442.3(to)-434.3(PBMt)]TJ
-1.0137 -1.1174 TD
[(suggests)-395.4(that)-397.5(the)-396.3(primary)-396.1(effect)-401.8(is)-393.8(to)-394(the)-396.3(metabolomics)-399.5(of)]TJ
0 -1.1116 TD
[(the)-390.5(body,)-388(which)-387.8(then)-391.6(communicates)-394.8(with)-385.7(the)-390.5(microbiome.)]TJ
T*
[(This)-523.9(healthy)-517.1(microbiome)-522.9(can,)-521.7(in)-520.7(turn,)-520.5(have)-519.3(a)-520.6(benecial)]TJ
0 -1.1174 TD
[(feedback)-456.9(to)-457.3(the)-453.8(body.)-451.3(One)-454.6(way)-454.6(that)-455.1(the)-459.6(microbiome)-453.8(can)]TJ
0 -1.1116 TD
[(communicate)-359.3(with)-351.1(the)-355.9(metabolome)-357.1(is)-353.5(by)-353.5(the)-350.2(production)-358(of)]TJ
T*
[(identical)-549.6(metabolites)-547.1(or)-549.3(metabolite)-546.1(mimics,)-549.4(including)]TJ
/F9 1 Tf
23.4593 0 TD
(a)Tj
/F6 1 Tf
.5011 0 TD
(-)Tj
-23.9604 -1.1174 TD
(MSH)Tj
7.3823 0 0 6.5614 83.2819 214.4692 Tm
(13)Tj
9.843 0 0 9.843 94.7338 210.0472 Tm
[(\(an)-413.4(antioxidant)-9.2(\),)-413.4(t)-12.7(r)-18.3(y)-12.6(p)-18.4(t)-12.7(o)-12.6(p)-18.4(h)-12.6(a)-19.5(n)-427.3(\()-18.3(a)-428.5(p)-12.6(r)-18.3(e)-13.8(c)-19.5(u)-12.6(r)-18.3(s)-12.4(o)-18.4(r)-427.3(t)-12.7(o)-433.1(s)-12.4(e)-19.5(r)-12.6(o)-18.4(-)]TJ
-3.3234 -1.1116 TD
.0131 Tc
[(t)-5.4(oni)-5.4(n)-356.6(a)-6.4(nd)-362.4(mel)-5.4(at)-5.4(on)-5.3(in\))-5.2(,)-358.9(an)-5.3(d)-356.6(o)-5.3(th)]TJ
12.6541 0 TD
.015 Tc
[(er)-360.4(kynurenine)-355.9(p)2.4(a)-4.5(t)2.3(hwa)-4.5(y)-354.7(me)-4.5(-)]TJ
-12.6541 -1.1116 TD
.0148 Tc
[(tabolites.)-345.7(The)-4.7(s)2.4(e)-350.3(metabolite)-4.7(s)-343.2(ca)-4.7(n)-343.4(i)2.1(nue)-4.7(nc)-4.7(e)-344.6(b)2.2(e)-4.7(h)2.2(aviors)-343.2(suc)-4.7(h)]TJ
T*
.013 Tc
[(as)-362.3(vis)-5.2(c)-.8(e)-6.5(r).4(a)-6.5(l)-356.8(pai)-5.5(n).4(,)-359(c)-.8(o)-5.4(g).4(n)-5.4(iti)-5.5(ve)-357.9(f)-5.3(u).4(n)-5.4(c)-.8(ti)-5.5(on)-5.4(,)-353.3(s)-5.2(oc)-6.5(ial)-356.8(b)-5.4(eh)-5.4(avi)-5.5(o).4(r)-5.3(s).6(,)-359(d).4(e)-6.5(-)]TJ
0 -1.1174 TD
[(p)-5.4(r).4(es)-5.2(si)-5.5(on)-5.4(,)-336(a)-.8(nd)-339.4(pot)-5.5(en)-5.4(ti)-5.5(al)]TJ
9.8664 0 TD
.0147 Tc
[(diseases)-337.5(such)-332(a)-4.8(s)-331.8(PD)-4.5(.)]TJ
7.3823 0 0 6.5614 245.0267 170.5889 Tm
.0233 Tc
[(14)8.8(,15)]TJ
9.843 0 0 9.843 72 155.2818 Tm
0 Tc
[(Th)19.6(e)-422.7(m)0(e)18.4(t)0(a)19.6(b)0(o)20.8(l)0(o)20.7(m)0(i)19.5(c)-422.7(an)19.7(d)-421.6(m)0(i)19.5(c)0(r)19.7(o)0(b)20.8(i)0(o)20.7(m)0(e)-413.5(e)0(f)19.7(f)0(e)19.7(c)0(t)19.5(s)-421.4(co)19.7(ul)14.9(d)-415.8(a)0(c)18.5(c)0(o)13.9(u)0(n)20.8(t)]TJ
-1.0137 -1.1116 TD
[(fo)20.9(r)-525.2(t)0(h)20.7(e)-520.6(de)19.7(la)19.6(ye)19.7(d,)-511.4(ab)19.7(sc)14.1(op)20.8(al)19.5(,)-521.8(a)0(n)19.7(d)-519.5(pr)20.9(ec)12.8(on)20.8(di)20.7(ti)20.6(on)20.8(in)15(g)-519.5(a)0(s)19.9(p)0(e)19.7(c)0(t)19.6(s)-525(of)]TJ
0 -1.1174 TD
[(PB)20(Mt)19.8(,)]TJ
7.3823 0 0 6.5614 87.4771 137.707 Tm
(2)Tj
9.843 0 0 9.843 93.4866 133.3417 Tm
[(su)15.3(ch)-228(as)-227.8(th)20.7(e)-238.4(n)0(e)19.7(u)0(r)15.1(o)0(p)20.8(r)0(o)20.9(t)0(e)19.6(c)0(t)19.5(i)0(o)20.7(n)-237.2(ag)13.9(ai)19.5(ns)21(t)-237.4(P)0(D)-227.5(s)0(e)19.9(e)0(n)-228(w)0(h)14.2(e)0(n)-228(t)0(h)20.7(e)]TJ
-3.1966 -1.1116 TD
[(abdomen)-408.7(is)-405.3(irradiated.)]TJ
7.3823 0 0 6.5614 153.1842 126.7653 Tm
(4)Tj
9.843 0 0 9.843 160.8944 122.3999 Tm
[(PBM)-402.5(inuences)-410.6(the)-407.8(metabolomics)]TJ
-10.0449 -1.1116 TD
[(of)-301.7(cytokine)-293.6(expression,)]TJ
7.3823 0 0 6.5614 154.6015 115.8235 Tm
(2)Tj
9.843 0 0 9.843 161.2913 111.4582 Tm
[(especiall)8.3(y)-300.6(IG-)]TJ
/F9 1 Tf
5.6906 0 TD
(c)Tj
/F6 1 Tf
.7372 0 TD
[(and)-304(the)-298.3(kynurenine)]TJ
-16.5131 -1.1174 TD
[(pathway,)-411.9(and,)-416.8(crucially,)]TJ
/F9 1 Tf
10.3444 0 TD
(a)Tj
/F6 1 Tf
.5011 0 TD
[(-MSH)-414.9(and)-413.4(its)-418.1(resultant)-409.8(cytokine)]TJ
-10.8455 -1.1116 TD
[(inhibitory)-432(melanocortin)-433(pathway.)-440.7(Interestin)9.6(gly,)-438.8(the)-442.3(micro-)]TJ
T*
[(biome)-468.8(also)-472(inuences)-468.2(these)-474.3(pathways,)-464.6(through)-468.6(release)-473(of)]TJ
0 -1.1174 TD
[(identical)-854.8(metabolites)-858.1(or)-854.6(mimicking)-854.8(molecules.)]TJ
7.3823 0 0 6.5614 268.8944 72 Tm
(13)Tj
9.843 0 0 9.843 284.7684 67.5779 Tm
(Pre-)Tj
-22.6299 -1.1116 TD
[(conditioning)-314.4(with)-322.3(PBMt)-323.1(does)-322.2(not)-320.2(have)-323.5(an)-325.9(immediate)-321.5(effect)]TJ
25.504 67.9184 TD
[(on)-376.6(healthy)-373.2(cells)-370.8(in)-376.7(e)-19.5(x)-24.1(p)-18.4(e)-19.5(r)-24.1(i)-18.5(m)-19.6(e)-25.3(n)-18.4(t)-18.5(a)-25.3(l)-392.9(m)-19.6(o)-24.1(d)-18.4(e)-19.5(l)-24.3(s)-398.3(b)-18.4(u)-18.4(t)-398.6(d)-18.4(o)-24.1(e)-19.5(s)-398.3(c)-19.5(h)-18.4(a)-25.3(n)-18.4(g)-18.4(e)]TJ
0 -1.1174 TD
.0186 Tc
[(m)-6.8(e)-.9(ta)-6.7(bol)-5.7(omi)-5.7(c)-432.9(fac)-6.7(t).1(or)-5.5(s)-431.6(t).1(ha)-6.7(t)-431.9(w)-.6(il)-5.7(l)-431.9(i).1(n)-5.5().4(ue)-6.7(nce)-432.9(t)-5.7(he)-432.9(im)-6.8(mune)-432.9(r)-5.5(e)-.9(-)]TJ
0 -1.1116 TD
.0204 Tc
[(sponse)-333.2(a)-4.9(n)2(d)-332(i)-3.9(mmune)-333.2(memory.)]TJ
7.3823 0 0 6.5614 436.0818 707.5841 Tm
.0299 Tc
(16)Tj
9.843 0 0 9.843 323.0361 692.277 Tm
0 Tc
[(The)-368.5(consideration)-369.3(of)-365(PBMt)-363.4(as)-366(an)-366.2(inuence)-363.6(of)-365(the)-367.5(meta-)]TJ
-1.0137 -1.1116 TD
[(bolomic)-258(as)-256.6(well)-260.1(as)-256.6(the)-252.3(genomic,)-262.5(proteomic,)-253.3(and)-257.9(microbiome)]TJ
0 -1.1174 TD
[(inuences)-387.6(is)-382.3(an)-383.5(important)-387.1(concept)-385.7(in)-382.5(the)-384.7(understanding)-385.3(of)]TJ
0 -1.1116 TD
[(respon)-7.5(siveness/unresponsiveness)-533.5(to)-526.5(treatment)-533.4(and)-528.6(the)-523(ef-)]TJ
T*
[(fective)-385.8(dose)-379.8(prescription)-378.5(for)-383.4(individualized)-382.4(precision)-380.9(med-)]TJ
0 -1.1174 TD
[(icine.)-368.6(T)15(h)16.2(e)-347.8(e)15(x)16.2(t)16.1(en)25.4(s)16.4(i)16.1(on)-330.5(of)-336.2(P)16.3(B)15.2(M)15.3(t)-346.8(f)16.2(r)0(o)26.6(m)-342.1(it)26.3(s)-346.5(w)15.3(e)15(l)0(l)]TJ
17.5556 0 TD
-.016 Tc
[(-doc)-16(u)9.4(ment)-16(e)9.3(d)-362.7(u).2(se)]TJ
-17.5556 -1.1116 TD
-.0157 Tc
[(i)-15.7(n)-386.6(pai)-15.7(n)-386.6(mana)-15.7(g)9.7(ement)-15.7(,)-389(wound)-402.7(repa)-15.7(i)9.6(r).5(,)-399.3(l).4(ymp)-15.7(h)10.9(oede)-15.7(m)8.5(a)-.7(,)-399.3(a)-.7(nd)-396.9(p)-15.7(r)10.9(e-)]TJ
T*
0 Tc
[(co)25.4(n)16.2(d)16.2(i)0(t)26.3(i)16.1(o)16.2(n)0(i)26.5(n)16.2(g)-438.8(f)16.2(or)-428.4(e)15(x)16.2(e)15(r)0(c)25.5(i)16.1(s)16.4(e)-440(an)25.4(d)-438.8(s)16.4(ur)26.6(g)16.2(e)15(r)16.2(y)0(,)-425(t)0(o)-428.5(i)16(t)16.1(s)-438.6(in)26.5(c)15(r)16.2(ea)24.3(s)16.4(i)16(ng)-428.4(u)16.2(s)16.4(e)]TJ
0 -1.1174 TD
-.0157 Tc
[(a)-15.7(s)-352.9(a)-363.5(t).3(r)-15.7(e)9.8(atmen)-15.7(t)-352.1(for)-368.1(neuro)-15.7(d)10.9(e)-.7(gen)-15.7(e)9.7(rat)-15.7(i)10.6(ve)-363.5(di)-15.7(s)11(eas)-15.7(e)9.9(,)-364.7(will)-362.5(r)-15.7(e)9.8(qui)-15.7(r)10.8(e)-363.5(an)]TJ
0 -1.1116 TD
-.016 Tc
[(e)-16(x)9.4(pan)-16(d)10.6(ed)-397.2(know)-16(l)9.6(e)-1(dg)-16(e)-382.2(o)-16(f)-381(t)-16(h)10.5(e)-1(se)-398.4(me)-16(t)9.3(a)-1(bol)-16(i)10.3(c)-398.4(proc)-16(e)8.3(sse)-16(s)9.6(.)-393.8(P)-16(B)9.7(Mt)-397.4(is)]TJ
T*
-.0156 Tc
[(s)-15.6(u)11.2(cce)-15.6(s)10(s).8(f)-15.6(u)11(l)-333.6(a)-.6(s)-333.3(a)-334.6(trea)-15.6(t)9.7(ment)-333.6(s).8(i)-15.6(n)10.9(ce)-334.6(it)-333.6(ta)-15.6(r)9.9(g).6(ets)-333.3(s)-15.6(p)11.2(eci)-15.6()11(c)-334.6(sit)-15.6(e)9.7(s,)-335.8(as)-333.3(op-)]TJ
T*
[(p)-15.7(o)10.9(sed)-339.3(t).4(o)-333.6(d)-15.7(r)10.9(u).5(g)-333.6(t)-15.7(h)10.8(e)-.7(rap)-15.7(y)-323.2(tha)-15.7(t)-324.5(can)-339.3(affe)-15.7(c)8.6(t)-333.7(man)-15.7(y)-323.2(\(of)-15.7(t)10.8(e)-.7(n)-333.6(u)-15.7(n)10.9(w)-.4(ant)-15.7(e)9.6(d\))]TJ
0 -1.1174 TD
[(s)-15.5(i)11.2(tes)-15.5(.)-359.7(P)-15.5(B)10.2(Mt)-373.8(at)-373.8(the)-374.9(c)-.5(or)-15.5(r)11.2(ect)-373.8(ef)-15.5(f)11.2(ect)-15.5(i)10.8(v).7(e)-374.9(w)-.2(av)-15.5(e)9.9(l).5(eng)-15.5(t)11(h,)-376(energ)-15.5(y)-357.5(d)-15.5(e)9.9(n-)]TJ
0 -1.1116 TD
0 Tc
[(si)26.7(t)16(y)0(,)-373.1(a)15(n)16.2(d)-387(f)16.2(r)16.2(e)0(q)25.4(u)16.2(e)15(n)16.2(cy)-372(c)15(a)0(n)-372(b)0(e)-372(e)15(ff)26.7(e)15(c)15(t)16.1(iv)26.5(e)15(l)16(y)-387(u)16.2(se)25.6(d)-381.2(i)0(n)-370.9(a)15(n)-387(i)16.1(nd)26.6(i)16.1(v)16.2(id)26.5(u)16.2(a)15(l)]TJ
T*
-.0159 Tc
[(w)-15.9(a)8.7(y)-477.8(t).2(o)-477.8(pro)-15.9(m)9.5(o).3(te)-478.9(home)-15.9(o)9.5(sta)-15.9(t)9.4(ic)-478.9(mecha)-15.9(n)9.5(isms)-477.6(w)-15.9(i)9.7(thi)-15.9(n)-461.7(t)-15.9(h)10.6(e)-478.9(body)-15.9(.)]TJ
0 -1.1174 TD
[(K)-15.9(n)9.8(owl)-15.9(e)9.4(dge)-283.1(of)-281.9(in)-15.9(d)10.7(i).2(vi)-15.9(d)10.6(u).3(al)-282.1(re)-15.9(s)9.7(pon)-15.9(s)10.9(e)-283.1(to)-281.9(lig)-15.9(h)10.7(t).2(,)-284.3(t).2(hro)-15.9(u)10.7(g).3(h)-281.9(g).3(en)-15.9(o)10.7(m)-.9(ics)-15.9(,)]TJ
0 -1.1116 TD
-.0156 Tc
[(e)-15.6(p)9.8(ige)-15.6(n)9.8(etic)-15.6(s)10(,)-468.3(and)-471.7(t).5(he)-467.1(m)-15.6(i)9.6(crob)-15.6(i)10.9(o).6(me,)-468.3(a)-15.6(s)-456.5(wel)-15.6(l)-455.8(as)-471.5(envi)-15.6(r)10.9(onmen)-15.6(t)10.9(a)-.6(l)]TJ
T*
-.0161 Tc
[(p)-16.1(a)9.3(rame)-16.1(t)9.2(e)-1.1(rs)-16.1(,)-319.9(i)0(s)-339.6(e)-1.1(sse)-16.1(n)9.3(tia)-16.1(l)-324.9(t)0(o)-334(t)0(hi)-16.1(s)-323.5(proc)-16.1(e)8.2(ss.)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 313.0582 480.5857 Tm
0 Tc
(References)Tj
/F6 1 Tf
9.2951 0 0 9.2951 317.707 464.5416 Tm
[(1.)-500.4(Burgos)-379.1(RCR,)-374.7(Schoeman)-382.2(JC,)-376.3(van)-376.7(Winden)-374.8(LJ,)-379.5(et)-376(al.)-376(Ultra-)]TJ
1.2503 -1.1223 TD
[(weak)-455.8(photon)-445.5(emission)-453.4(as)-448.8(a)-449.6(dynamic)-447.6(tool)-450.8(for)-450.3(monitoring)]TJ
0 -1.1284 TD
[(oxidative)-337.4(stress)-339.6(metabolism.)-335.8(Sci)-330.2(Rep)-338.8(2017;7:1229.)]TJ
-1.2503 -1.1223 TD
[(2.)-500.4(Hamblin)-487.1(MR.)-486.2(Mechanisms)-492.4(and)-480.4(applications)-493(of)-484.5(the)-485.9(anti-)]TJ
1.2503 -1.1284 TD
[(inammatory)-482.9(effects)-486.5(of)-484.4(photobiomodulation.)-479.4(AIMS)-482.4(Bio-)]TJ
0 -1.1223 TD
[(phys)-335.2(2017;4:337361.)]TJ
-1.2503 -1.1284 TD
.0203 Tc
[(3)20.3(.)-480.1(H)-5.8(a)-2.3(ld)-4.2(eman)-339.7(S,)-333.5(C)-2.9(a)-2.3(rro)-4.2(ll)-339.1(L,)-333.5(C)-2.9(a)-2.3(s)-3.4(s)-3.3(id)-4.2(y)-333.6(J)-3.4(D,)-333.5(Sch)-4.2(u)1.9(b)-4.2(e)-2.3(rt)-333(J)-3.3(,)-339.6(Nyg)-4.2(r)-.5(en)]TJ
1.2503 -1.1284 TD
0 Tc
(A)Tj
.2013 .244 TD
()Tj
.5428 -.244 TD
.0216 Tc
[(.)-368.8(T)1.3(he)-367(bone)-373.1(and)-368.9(j)-2.4(oint)-374.4(decade)-367(2)-2.9(0002010)-375(task)-368.9(force)-367(o)-2.9(n)]TJ
-.7441 -1.1223 TD
.0222 Tc
[(neck)-276.8(pain)-276.8(and)-276.8(i)4.3(ts)-282(a)5.7(s)-1.4(sociate)5.7(d)-282.9(disorders.)-282.8(Eur)-279.1(S).9(pine)-281(J)-275.9(2)3.8(008;)]TJ
0 -1.1284 TD
.0243 Tc
[(17)5.9(:5)5.9(7)5.9(.)]TJ
-1.2503 -1.1223 TD
0 Tc
[(4.)-500.4(Johnstone)-326.4(D,)-319(Massri)-321.5(N,)-319(Moro)-325.4(C,)-316.1(et)-327.2(al.)-321.1(Indirect)-318(application)]TJ
1.2503 -1.1284 TD
[(of)-393(near)-395.6(infrared)-394.1(light)-389.4(induces)-398.3(neuroprotection)-389.8(in)-396.2(a)-388.6(mouse)]TJ
0 -1.1223 TD
[(model)-376(of)-374.7(parkinsonisman)-375.7(abscopal)-372.2(neuoroprotective)-375.8(ef-)]TJ
0 -1.1284 TD
[(fect.)-340.2(Neuroscience)-336.3(2014;274:93101.)]TJ
-1.2503 -1.1223 TD
[(5.)-500.4(Trajano)-446.1(LAdSN,)-447.9(da)-443.6(Silva)-439.7(Sergio)-442.8(LP,)-444.3(Stumbo)-441.9(AC,)-445.9(Men-)]TJ
1.2503 -1.1284 TD
[(calha)-464.1(AL,)-461.3(Fonseca)-460.9(ADS.)-464(Low)-455.2(power)-466.3(lasers)-460.6(on)-457.7(genomic)]TJ
0 -1.1223 TD
[(stability.)-337.3(J)-334.7(Photochem)-334.9(Photobiol)-331.8(B)-334.3(2018;180:186197.)]TJ
-1.2503 -1.1284 TD
[(6.)-500.4(Liebert)-433.3(A,)-428.7(Bicknell)-433.5(B,)-425.8(Adams)-432.1(R.)-425.8(Protein)-430.1(conformational)]TJ
1.2503 -1.1223 TD
[(modulation)-442.7(by)-439.4(photons:)-438.3(a)-437.4(mechanism)-444.7(for)-438.1(laser)-443(treatment)]TJ
0 -1.1284 TD
[(effects.)-340.1(Med)-333.3(Hypotheses)-338.5(2014;82:275281.)]TJ
-1.2503 -1.1223 TD
[(7.)-500.4(Stojkovic)-451.9(K,)-447(Wing)-443.5(SS,)-451.4(Cermakian)-447(N.)-447(A)-447(central)-447.9(role)-451.8(for)]TJ
1.2503 -1.1284 TD
[(ubiquitination)-265.1(within)-256.9(a)-260.5(circadian)-263.3(clock)-258.6(protein)-256.5(modication)]TJ
0 -1.1223 TD
[(code.)-338.4(Front)-334.7(Mol)-334.6(Neurosci)-335.3(2014;7:69.)]TJ
-1.2503 -1.1284 TD
[(8.)-500.4(Laakso)-254.3(EL,)-248.1(Cramond)-249.8(T,)-252.2(Richardson)-247.3(C,)-249(Galligan)-253.4(JP.)-246.3(Plasma)]TJ
1.2503 -1.1223 TD
[(ACTH)-236.1(and)]TJ
/F9 1 Tf
4.6354 0 TD
(b)Tj
/F6 1 Tf
.555 0 TD
[(-endorphin)-229.3(levels)-239(in)-231.5(response)-235.8(to)-237.6(low)-233.2(level)-233.7(laser)]TJ
-5.1905 -1.1284 TD
[(therapy)-401.5(\(LLLT\))-397.3(for)-395.4(myofascial)-398.2(trigger)-399.1(points.)-395.4(Laser)-396.7(Ther)]TJ
0 -1.1223 TD
(1994;6:133141.)Tj
-1.2503 -1.1284 TD
[(9.)-500.4(Nakahata)-372.7(Y,)-367.8(Bessho)-367.9(Y.)-373.8(The)-366.4(circadian)-373.1(NAD)]TJ
/F8 1 Tf
6.9712 0 0 6.196 498.7274 186.2361 Tm
(+)Tj
/F6 1 Tf
9.2951 0 0 9.2951 505.9841 182.0976 Tm
(metabolism:)Tj
-19.0052 -1.1223 TD
[(impact)-239.5(on)-232.1(chromatin)-236.1(remodeling)-236.3(and)-236.4(aging.)-236.2(Biomed)-234.5(Res)-234.2(Int)]TJ
0 -1.1284 TD
[(2016,)-336.1(Article)-334.9(ID)-333.5(3208429,)-336.6(7)-329.5(pp.)]TJ
-1.7505 -1.1223 TD
[(10.)-500.5(Z)-8.1(h)-6.2(an)-10.6(g)-512.5(Y)-7.8(,)-506.3(K)-7.8(o)-6.2(r)0(n)-8.7(h)-6.2(au)-10.6(se)-15.8(r)-508.7(J)0(,)-517.8(Z)-8.1(ee)-514.9(P)-9.1(,)-506.3(Ma)-15.9(y)-6.2(o)-506.4(K)-7.8(,)-512.4(Ta)-12.5(k)-6.2(a)0(h)-10.6(a)0(s)-9.7(h)-6.2(i)-511.9(J)0(,)]TJ
1.7505 -1.1284 TD
[(T)-8.1(u)-6.2(re)-12.9(k)-372.2(F)0(.)-381.3(E)0(f)-10.6(f)0(e)-12.9(c)0(t)-10(s)-371.3(o)-6.2(f)-374.5(ag)-10.6(in)-11.9(g)-372.2(o)-6.2(n)-372.2(l)0(i)-11.3(g)-6.2(h)-6.2(t)0(-)-8.1(i)0(n)-11.9(d)-6.2(u)-6.2(c)0(e)-14.8(d)-372.2(p)-6.2(h)0(a)-10.6(s)0(e)-9.7(-)-8.6(sh)-11.6(if)-8.1(ti)-11.3(n)-6.2(g)]TJ
0 -1.1223 TD
[(o)-6.2(f)-240.3(c)-10.4(i)0(r)-8.1(c)0(a)-14.8(d)-6.2(ia)-10(n)-238(b)-6.2(eh)-10.6(a)-10.4(vio)-12.1(r)-8.6(a)0(l)-247.9(r)0(h)-8.7(y)-6.2(th)-11.9(ms)-11.2(,)-237.9(F)-9.1(os)-243.4(ex)-10.6(p)-6.2(r)-8.6(es)-9.7(si)-11(o)-6.2(n)-238(an)-10.6(d)-244.1(C)0(R)-9.8(E)-8.1(B)]TJ
0 -1.1284 TD
.008 Tc
[(phos)8(p)-3.6(hor)8(yl)8(at)8(i)-3.3(o)1.8(n)-443.5(i)8(n)-449.1(t)8(h)-3.9(e)-447.7(h)8(a)-2.6(m)8(s)-3.2(t)8(e)-2(r)-445.8(s)8(u)-3.6(p)1.8(r)8(a)8(c)-9.3(hi)8(as)8(ma)8(ti)8(c)-453.4(n)1.8(u)8(c)-2.6(l)8(e)-2(us)8(.)]TJ
0 -1.1223 TD
.0075 Tc
[(Ne)7.5(uros)7.5(ci)7.5(ence)-326.2(1996;)7.5(7)-4.4(0)1.3(:)7.5(9)7.5(5)-4.6(1961.)]TJ
-1.7505 -1.1284 TD
.012 Tc
[(1)12(1)12(.)-488.5(Bick)5.8(nell)-463.3(B,)-457.7(Lieb)5.8(ert)-457.2(A)-1.9(,)-457.7(J).5(ohnst)12(o)-6(ne)-462(D,)-457.7(Kiat)-463.3(H.)-457.7(Ph)5.8(otobio)5.8(-)]TJ
1.7505 -1.1223 TD
[(modulatio)5.8(n)-262.6(o)-.3(f)-258.8(t).2(h)5.8(e)-260.7(microb)5.8(iome:)-262(i).2(mp)5.8(licat)12(i)-5.4(ons)-261.7(for)-258.8(m).1(etabolic)]TJ
0 -1.1284 TD
.0122 Tc
[(an)6(d)-335.6(i).4(nammatory)-335.6(d)6(i).4(seases.)-329.4(L)-2(asers)-328.6(M).6(ed)-329.5(Sci)-328.9(2018)6(:111)6(.)]TJ
-1.7505 -1.1223 TD
0 Tc
[(12.)-500.5(Blivet)-368(G,)-361.6(Meunier)-364.2(J,)-359.2(Roman)-363(FJ,)-362.2(Touchon)-360.9(J.)-365.3(Neuroprotec-)]TJ
1.7505 -1.1284 TD
[(tive)-339.1(effect)-334.7(of)-338.1(a)-333.7(new)-335.6(photobiomodulation)-339(technique)-336(against)]TJ
/F10 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(2)Tj
45.4933 0 TD
[(GUEST)-336.1(EDITORIAL)]TJ
ET
endstream
endobj
25 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
9.2951 0 0 9.2951 76.0252 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
(A)Tj
/F9 1 Tf
.7197 0 TD
(b)Tj
/F6 1 Tf
.555 0 TD
[(2535)-378.9(peptide-induced)-391.7(toxicity)-381.2(in)-384(mice:)-385.7(novel)-382.5(hypoth-)]TJ
-1.2747 -1.1223 TD
[(esis)-398.9(for)-395.4(therapeutic)-397.2(approach)-394.3(of)-393(Alzheimers)-402.2(disease)-395.5(sug-)]TJ
0 -1.1284 TD
[(gested.)-337.3(Alzheimers)-338.8(Dement)-333.1(\(NY\))-337.7(2018;4:5463.)]TJ
-1.7505 -1.1223 TD
[(13.)-500.5(Hsiao)-255.1(WW,)-253(Metz)-257.7(C,)-255.1(Singh)-253.1(DP,)-248.8(Roth)-254.9(J.)-255.5(The)-250.5(microbes)-254(of)-252.7(the)]TJ
1.7505 -1.1283 TD
[(intestine:)-390.4(an)-388.7(introduction)-390.2(to)-390.1(their)-390.4(metabolic)-389.9(and)-388.9(signaling)]TJ
0 -1.1223 TD
[(capabilities.)-508.9(Endocrinol)-496.7(Metab)-501.9(Clin)-504.3(North)-498.1(Am)-501.6(2008;37:)]TJ
0 -1.1284 TD
(857871.)Tj
-1.7505 -1.1223 TD
[(14.)-500.5(Hartai)-286.5(Z,)-282.7(Klivenyi)-285.8(P,)-277.6(Janaky)-289(T,)-282.7(Penke)-280.4(B,)-285.6(Dux)-282.6(L,)-282.7(Vecsei)-282(L.)]TJ
1.7505 -1.1284 TD
[(Kynurenine)-281.6(metabolism)-287(in)-280.3(plasma)-281.9(and)-279.1(in)-280.3(red)-281.4(blood)-280.7(cells)-281.6(in)]TJ
0 -1.1223 TD
[(Parkinsons)-340.4(disease.)-334.6(J)-334.7(Neurol)-331.7(Sci)-336.3(2005;239:3135.)]TJ
-1.7505 -1.1284 TD
[(15.)-500.5(Kennedy)-395.3(PJ,)-392.7(Cryan)-390.2(JF,)-392.7(Dinan)-396.3(TG,)-388.1(Clarke)-400.1(G.)-392.1(Kynurenine)]TJ
1.7505 -1.1223 TD
[(pathway)-602.1(metabolism)-598(and)-602.4(the)-595.7(microbiota-gut-brain)-600.9(axis.)]TJ
0 -1.1284 TD
[(Neuropharmacology)-341.7(2017;112:399412.)]TJ
25.263 13.5037 TD
[(16.)-500.5(Rana)-422.4(G,)-422.6(Donizetti)-423.7(A,)-422.6(Virelli)-427.7(G,)-422.6(et)-424.8(al.)-418.7(Cortical)-429.7(spreading)]TJ
1.7505 -1.1223 TD
[(depression)-418.5(differentially)-427.4(affects)-419.4(lysine)-423.9(methylation)-422(of)-417.3(H3)]TJ
0 -1.1284 TD
[(histone)-485(at)-491.9(neuroprotective)-491.6(genes)-490.1(and)-486.5(retrotransposon)-490.4(se-)]TJ
0 -1.1223 TD
[(quences.)-336.1(Brain)-334.7(Res)-331.8(2012;1467:113119.)]TJ
9.843 0 0 9.843 438.803 672.3778 Tm
[(Address)-331.9(correspondence)-343.5(to:)]TJ
/F7 1 Tf
6.4451 -1.1116 TD
[(Ann)-332.8(Liebert)]TJ
-7.9599 -1.1174 TD
[(Australasian)-336.8(Research)-341.4(Institute)]TJ
4.5559 -1.1116 TD
[(185)-331.6(Foxvalley)-338.6(Road)]TJ
-1.3881 -1.1116 TD
[(Wahroonga,)-336.8(NSW)-333.7(2076)]TJ
5.9095 -1.1174 TD
(Australia)Tj
-9.9009 -1.8201 TD
(E-mail:)Tj
/F6 1 Tf
3.3982 0 TD
(ann.liebert@outlook.com)Tj
/F10 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
(LIEBERT)Tj
54.1178 0 TD
(3)Tj
ET
endstream
endobj
29 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
30 0 obj
<>stream
8;Z\7!>:&.#k\-=j?#;%=b_GLR*K!]geD?s],Mpq][7;t73Ioi!MF=+&AoqX,5K/;
s$)Xks5S;?pJ%D7Bo_`>:t\j=qc>f[^6"BoL]NVr;7k+)1"4r)6?u!6]$\d8OeC\P
<'oJa*#FspZ^JJ"$G&oq;hc_;eXEB2il\>f03.N$-as4(ThnjR&]q']X-8lt_kV[G
V1#FP_W&sh07uXcKnK?`GnK'h^H/VV]I,^_X%=q>PjTK@b.^FS;A92THjLiA?"/9K0I&\tHn+c`u3bHn))
(4u!6JA@W7QVjLgbFp=\UUYI]+0hu+,ef>kr?\]a)43#.bK2iQVg;]bQ0d#ACnZIY
au..i28Ck?W_oNndbRhJ=Q>f"1fHG:)jX1Q_lO`]+0?+%pc8#Zn]TYK`Ff0RH?>)~>
endstream
endobj
15 0 obj
<>stream
8;Z\76#m)O#k\-=oK,(/P!s(':tS@9QIF%`:"(RQF+3Jo`^.\Le^J6;6-UAJPJ#DX
nT[3E_2FBKl\4oUlo[>Sl=&/J]1.htq@m$F;Pt;D6%ojFEM@Al[0YXeBG=>jP9Y=_GrQL](#
8gTRm%bC&-Q^F3Sk78@'C8IVM2!Td.B6_PS*DO.fcmc3%96am5oc<9c%cAV9bXB$E
`s/7OO<,(7;:*uU^Ho.qo\q'JH]E72,fk:6KGk+NE'];4_.u
endstream
endobj
26 0 obj
<>stream
8;Z]]9+HIp$q4%e^VOg.kWnsN'H5>cgbU'-?tl6j+'WR$e8h]!-*TJ@iX=AU2YXe&:1kZIAPQ\T;?#*n
<'R/nr#+fI6T:8&glnp2zzpp";h>;c~>
endstream
endobj
34 0 obj
<>
endobj
35 0 obj
<>stream
HdVnF}Wq Xd\4@-ÚZIl)R W:%m0`.gΜ>Sa2mwڬ$Z3oKiJg]AmwK|cV_QCʅK
L%_K[%0r1=$%hS 0ϱQ].cJ֪@PJϏjA̖ eE/N